The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
CX3CL1/CX3CR1-Mediated Microglia Activation Plays a Detrimental Role in Ischemic Mice Brain via p38MAPK/PKC Pathway
Abstract
The exact roles of activated microglia and fractalkine (CX3CL1)/fractalkine receptor (CX3CR1) signaling are not fully understood in brain ischemic injury and the findings reported are controversial. Here, we investigated the effects of CX3CR1 siRNA on the expression of CX3CR1, p38 mitogen-activated protein kinase (p38MAPK), Protein Kinase C (PKC) and inflammatory cytokines, microglia activation, white matter lesions, and cognitive function in mice treated with bilateral common carotid artery stenosis (BCAS) in vivo as well as effects of exogenous CX3CL1, CX3CR1 siRNA, and SB2035080 on expression of inflammatory cytokines in BV2 microglia treated with oxygen–glucose deprivation (OGD) in vitro. We showed that CX3CR1 siRNA significantly inhibited the increased expression of CX3CR1, p38MAPK, PKC as well as tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6, and also attenuated microglia activation, white matter lesions, and cognitive deficits induced by BCAS in mice brain. We also showed that exogenous CX3CL1 could induce a further enhancement in TNF-α and IL-1β expression, which could be suppressed by CX3CR1 siRNA or by the p38MAPK inhibitor in OGD-treated BV2 microglial cells in vitro. Our findings indicated that CX3CL1/CX3CR1-mediated microglial activation plays a detrimental role in ischemic brain via p38MAPK/PKC signaling and also suggested that CX3CL1/CX3CR1 axis might be a putative therapeutic target to disrupt the cascade of deleterious events that lead to brain ischemic injury.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“many studies have confirmed that the CX3CL1/CX3CR1 axis plays an important role in regulating microglial activation and neuroinflammation [26, 27].”
From CX3CL1/CX3CR1 axis attenuates early brain injury via promoting the delivery of exosomal microRNA-124 from neuron to microglia after subarachnoid hemorrhage (2020) · cites this paper as [27]
Citations
Cites
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
White Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion
Shibata, M., Ohtani, R., Ihara, M., & Tomimoto, H. (2004) · Stroke · doi:10.1161/01.str.0000143725.19053.60 · Cited by 583
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
Gudi, V., Gingele, S., Skripuletz, T., & Stangel, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00073 · Cited by 375
Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury
Soriano, S. G., Amaravadi, L. S., Wang, Y. F., Zhou, H., Yu, G. X., Tonra, J. R., Fairchild-Huntress, V., Fang, Q., Dunmore, J. H., Huszar, D., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00033-4 · Cited by 222
Lipopolysaccharides Upregulate Hepcidin in Neuron via Microglia and the IL-6/STAT3 Signaling Pathway
Qian, Z.-M., He, X., Liang, T., Wu, K.-C., Yan, Y.-C., Lu, L.-N., Yang, G., Luo, Q. Q., Yung, W.-H., & Ke, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8671-3 · Cited by 89
Self-citation
Research works printed but not linked: 40
- 10.1016/0166-2236(96)10049-7 · DOI · Paper page
- 10.1126/science.1110647 · DOI · Paper page
- 10.1038/nn1997 · DOI · Paper page
- 10.1186/1742-2094-11-13 · DOI
- 10.1073/pnas.95.26.15769 · DOI · Paper page
- 10.1523/JNEUROSCI.5360-06.2007 · DOI · Paper page
- 10.1007/s11011-014-9531-6 · DOI
- 10.1016/S0166-2236(99)01453-8 · DOI
- 10.1128/MCB.20.11.4106-4114.2000 · DOI · Paper page
- 10.5551/jat.11.15 · DOI
- 10.1016/S0092-8674(00)80438-9 · DOI
- 10.1517/14728222.2012.682574 · DOI
- 10.1098/rsob.130181 · DOI
- 10.1038/jcbfm.2008.64 · DOI · Paper page
- 10.1186/1742-2094-11-26 · DOI
- 10.1523/JNEUROSCI.3611-11.2011 · DOI · Paper page
- 10.1002/glia.22474 · DOI
- 10.1016/j.ejphar.2013.01.072 · DOI
- 10.1111/j.1476-5381.2011.01337.x · DOI
- 10.1016/S0006-8993(96)01453-9 · DOI · Paper page
- 10.1097/00004647-199805000-00012 · DOI
- 10.1371/journal.pone.0052566 · DOI
- 10.1016/S0014-4886(03)00123-7 · DOI
- 10.1124/mol.105.017756 · DOI
- 10.1002/glia.21166 · DOI
- Mannix R, 2014, J Neurosurg, 30, 1
- 10.1371/journal.pone.0057827 · DOI
- 10.1523/JNEUROSCI.22-01-00038.2002 · DOI
- 10.1016/j.pneurobio.2005.02.004 · DOI · Paper page
- 10.1007/s11481-013-9490-4 · DOI
- 10.1073/pnas.95.18.10896 · DOI · Paper page
- 10.1046/j.1460-9568.2002.02007.x · DOI
- 10.1016/j.bbi.2006.12.004 · DOI
- 10.1182/blood-2011-04-348946 · DOI
- 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V · DOI
- 10.1016/j.it.2004.09.015 · DOI · Paper page
- 10.1038/nri1733 · DOI · Paper page
- 10.1038/nrn3053 · DOI · Paper page
- 10.4049/jimmunol.0903212 · DOI
- 10.1007/s00011-013-0687-z · DOI
Cited by
Sorted by citations
Tissue-specific Role of CX3CR1 Expressing Immune Cells and Their Relationships with Human Disease
Lee, M., Lee, Y., Song, J., Lee, J., & Chang, S.-Y. (2018) · Immune Network · doi:10.4110/in.2018.18.e5 · Cited by 260
“However, inhibiting CX3CR1 expression by siRNA can decrease TNF-α and IL-1β cytokine production in a different ischemic animal model (50).”
BackgroundChen, X., Jiang, M., Li, H., Wang, Y., Shen, H., Li, X., Zhang, Y., Wu, J., Yu, Z., & Chen, G. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01882-6 · Cited by 85
Tang, M.-M., Lin, W.-J., Pan, Y.-Q., & Li, Y.-C. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00255 · Cited by 73
“Depending on the disorder or the course of brain injury, CX3CL1 contributes to augment microglia pro-inflammatory response or maintain microglia in quiescence (Liu et al., 2015; Zanier et al., 2016; Dorfman et al., 2017).”
Background
Metadata
- Authors
- Liu, Y., Wu, X.-M., Luo, Q.-Q., Huang, S., Yang, Q.-W. Q., Wang, F.-X., Ke, Y., & Qian, Z.-M.
- Affiliations
- Department of Neurology, Xinqiao Hospital, The Third Military Medical University, Chongqing, China
- Department of Neurobiology, Institute for Nautical Medicine, Nantong University, Nantong, China
- Laboratory of Neuropharmacology, Fudan University School of Pharmacy, Pu Dong, Shanghai, China
- School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, New Territories, Hong Kong, China
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2015-05-13
- Volume
- 35
- Issue
- 10
- Pages
- 1623-1631
- ISSN
- 0271-678X
- 1559-7016
- Cited by
- 84
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review